Cancer Research Audrey Hepburn  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 6068-6073, December 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Waheed, I.
Right arrow Articles by Schrump, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Waheed, I.
Right arrow Articles by Schrump, D. S.
[Cancer Research 59, 6068-6073, December 15, 1999]
© 1999 American Association for Cancer Research


Advances in Brief

Antisense to SV40 Early Gene Region Induces Growth Arrest and Apoptosis in T-Antigen-positive Human Pleural Mesothelioma Cells

Ishrat Waheed, Z. Sheng Guo, G. Aaron Chen, Todd S. Weiser, Dao M. Nguyen and David S. Schrump1

Thoracic Oncology Section, Surgery Branch, National Cancer Institute, NIH, Bethesda, Maryland 20892

Although SV40 oncoproteins have been detected in malignant pleural mesotheliomas (MPMs), their role in the pathogenesis and clinical behavior of these neoplasms remains controversial. In the present study, we sought to define the relevance of SV40 T/t antigen expression in established human mesothelioma cell lines deficient for p16INK4a as well as ARF expression. SV40 early region sequences were readily detected in genomic DNA isolated from pleural mesothelioma lines; however, levels of SV40 T/t antigen expression were highly variable in these cells. An adenoviral vector expressing an antisense transcript to SV40 early region inhibited T antigen expression and mediated significant growth inhibition and apo-ptosis in T-antigen-positive mesothelioma cells and SV40-transformed COS-7 cells. Abrogation of T/t antigen expression coincided with enhanced p21/WAF-1 expression, suggesting that restoration of p53-mediated pathways may have contributed to the growth inhibition and apo-ptosis induced by the antisense construct. These effects were not observed after similar treatment of mesothelioma or lung cancer cells containing no SV40 DNA sequences. Collectively, these data suggest that SV40 oncoproteins contribute to the malignant phenotype of pleural mesotheliomas and indicate that interventions designed to abrogate their expression may be efficacious in the treatment of individuals with these neoplasms.




This article has been cited by other articles:


Home page
Mult SclerHome page
K Khalili and M K White
Human demyelinating disease and the polyomavirus JCV
Multiple Sclerosis, April 1, 2006; 12(2): 133 - 142.
[Abstract] [PDF]


Home page
Cancer Res.Home page
J. J. Manfredi, J. Dong, W.-j. Liu, L. Resnick-Silverman, R. Qiao, P. Chahinian, M. Saric, A. R. Gibbs, J. I. Phillips, J. Murray, et al.
Evidence against a Role for SV40 in Human Mesothelioma
Cancer Res., April 1, 2005; 65(7): 2602 - 2609.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. M. Nguyen, W. D. Schrump, G. A. Chen, W. Tsai, P. Nguyen, J. B. Trepel, and D. S. Schrump
Abrogation of p21 Expression by Flavopiridol Enhances Depsipeptide-Mediated Apoptosis in Malignant Pleural Mesothelioma Cells
Clin. Cancer Res., March 1, 2004; 10(5): 1813 - 1825.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. L. Garcea and M. J. Imperiale
Simian Virus 40 Infection of Humans
J. Virol., May 1, 2003; 77(9): 5039 - 5045.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Vivaldi, F. Pacini, F. Martini, L. Iaccheri, F. Pezzetti, R. Elisei, A. Pinchera, P. Faviana, F. Basolo, and M. Tognon
Simian Virus 40-Like Sequences from Early and Late Regions in Human Thyroid Tumors of Different Histotypes
J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 892 - 899.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
C. A. Vaslet, N. J. Messier, and A. B. Kane
Accelerated Progression of Asbestos-Induced Mesotheliomas in Heterozygous p53+/- Mice
Toxicol. Sci., August 1, 2002; 68(2): 331 - 338.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
A Baldi, A M Groeger, V Esposito, R Cassandro, G Tonini, T Battista, M P Di Marino, B Vincenzi, M Santini, A Angelini, et al.
Expression of p21 in SV40 large T antigen positive human pleural mesothelioma: relationship with survival
Thorax, April 1, 2002; 57(4): 353 - 356.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Cacciotti, R. Libener, P. Betta, F. Martini, C. Porta, A. Procopio, L. Strizzi, L. Penengo, M. Tognon, L. Mutti, et al.
SV40 replication in human mesothelial cells induces HGF/Met receptor activation: A model for viral-related carcinogenesis of human malignant mesothelioma
PNAS, September 19, 2001; (2001) 211026798.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C.-T. Yang, L. You, K. Uematsu, C.-C. Yeh, F. McCormick, and D. M. Jablons
p14ARF Modulates the Cytolytic Effect of ONYX-015 in Mesothelioma Cells with Wild-type p53
Cancer Res., August 1, 2001; 61(16): 5959 - 5963.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. D. Schell, B. B. Knowles, and S. S. Tevethia
Sequential Loss of Cytotoxic T Lymphocyte Responses to Simian Virus 40 Large T Antigen Epitopes in T Antigen Transgenic Mice Developing Osteosarcomas
Cancer Res., June 1, 2000; 60(11): 3002 - 3012.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
S. M. Dubinett, R. K. Batra, P. W. Miller, and S. Sharma
Tumor Antigens in Thoracic Malignancy
Am. J. Respir. Cell Mol. Biol., May 1, 2000; 22(5): 524 - 527.
[Full Text]


Home page
JNCI J Natl Cancer InstHome page
J. S. Butel and J. A. Lednicky
RESPONSE: More About: Cell and Molecular Biology of Simian Virus 40: Implications for Human Infections and Disease
J Natl Cancer Inst, March 15, 2000; 92(6): 496 - 497.
[Full Text] [PDF]


Home page
Cancer Res.Home page
P. Rizzo, I. D. Resta, A. Powers, H. Ratner, and M. Carbone
Unique Strains of SV40 in Commercial Poliovaccines from 1955 Not Readily Identifiable with Current Testing for SV40 Infection
Cancer Res., December 1, 1999; 59(24): 6103 - 6108.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Bocchetta, I. Di Resta, A. Powers, R. Fresco, A. Tosolini, J. R. Testa, H. I. Pass, P. Rizzo, and M. Carbone
From the Cover: Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity
PNAS, August 29, 2000; 97(18): 10214 - 10219.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Cacciotti, R. Libener, P. Betta, F. Martini, C. Porta, A. Procopio, L. Strizzi, L. Penengo, M. Tognon, L. Mutti, et al.
SV40 replication in human mesothelial cells induces HGF/Met receptor activation: A model for viral-related carcinogenesis of human malignant mesothelioma
PNAS, October 9, 2001; 98(21): 12032 - 12037.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.